(S)-tetrahydrofuran-3-ol(for Empagliflozin & afatinib)CAS:86087-23-2

(S)-tetrahydrofuran-3-ol serves as an important building block in the synthesis of these pharmaceutical compounds. Empagliflozin is an oral medication used to treat type 2 diabetes by inhibiting glucose reabsorption in the kidneys. Afatinib, on the other hand, is a tyrosine kinase inhibitor employed in the treatment of certain types of lung cancer. The unique structure of (S)-tetrahydrofuran-3-ol allows for its incorporation into the molecular framework of these drugs, contributing to their pharmacological activities and therapeutic effects. It plays a crucial role in the development of the desired stereoselectivity and functional groups necessary for the desired drug properties. Overall, (S)-tetrahydrofuran-3-ol is an essential component in the synthesis of pharmaceutical drugs like Empagliflozin and Afatinib. Its utilization in organic synthesis and pharmaceutical research enables the advancement of treatments for diabetes and cancer, making it a valuable tool in the field of medicinal chemistry.